Exelixis (EXEL) Liabilities and Shareholders Equity (2010 - 2026)

Exelixis' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $2.6 billion for Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 8.59% year-over-year to $2.6 billion in Q2 2026; TTM through Apr 2026 was $10.9 billion, a 5.02% decrease from a year earlier, with the FY2026 full-year figure at $2.8 billion, down 3.5% from the prior year.
• Liabilities and Shareholders Equity fell to $2.6 billion in Q2 2026 per EXEL's latest filing, from $2.8 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $3.1 billion in Q1 2023 and bottomed at $2.6 billion in Q2 2026.
• The 5-year median for Liabilities and Shareholders Equity is $2.9 billion (2022), against an average of $2.9 billion.
• Across the five-year window, Liabilities and Shareholders Equity gained 21.72% in 2022 and dropped 11.75% in 2024, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $3.1 billion in 2022, then decreased by 4.2% to $2.9 billion in 2023, then advanced by 0.61% to $3.0 billion in 2024, then slipped by 4.62% to $2.8 billion in 2025, then slipped by 8.14% to $2.6 billion in 2026.
• Per Business Quant, the three latest EXEL Liabilities and Shareholders Equity figures stand at $2.6 billion (Q2 2026), $2.8 billion (Q1 2026), and $2.8 billion (Q4 2025).